Clinical NewsCorrectionOct 4, 2004 In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.Latest in Clinical NewsAmyloid PET scans validated in racially diverse patientsAugust 1, 2025Limited access to PCPs thwarts mammography screening uptakeAugust 1, 2025POCUS rules out pulmonary congestion in kidney patientsAugust 1, 2025Mayo Clinic highlights radiopharmaceutical for breast cancer treatmentAugust 1, 2025Related StoriesBreastWhen push comes to shove: Addressing compression in mammographyBreastPreparation key to surviving MQSA inspectionsClinical NewsBiochem enters ultrasound domain in fetal screeningBreastBreast Imaging: The Requisites